Literature DB >> 23277765

Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.

Bryan J Weiner1, Sara R Jacobs, Lori M Minasian, Marjorie J Good.   

Abstract

PURPOSE: To examine the organizational design features that were consistently associated in 2010 with high levels of patient enrollment onto National Cancer Institute (NCI) cancer treatment trials among the oncology practices and hospitals participating in the NCI Community Clinical Oncology Program (CCOP).
METHODS: Fuzzy-set qualitative comparative analysis was used to identify the recipes (ie, combinations of organizational design features) that CCOPs used to achieve high levels of patient enrollment onto NCI treatment trials in 2010. Four organizational design features were examined: number of open treatment trials with at least one patient enrolled, number of newly diagnosed patients with cancer, number of CCOP-affiliated physicians, and number of CCOP-affiliated hospitals or practices where patient enrollment could occur. Data were obtained from NCI data systems and CCOP grant progress reports.
RESULTS: Two recipes were consistently associated with high levels of patient enrollment onto NCI treatment trials in 2010: having many open treatment trials and many new patients with cancer, and having many open treatment trials and many affiliated hospitals or practices. Together, these recipes accounted for nearly two thirds of CCOP membership in the high-performance set in 2010.
CONCLUSION: No single organizational design feature, by itself, was consistently associated with high levels of patient enrollment onto NCI treatment trials in 2010. Having a large menu of active treatment trials may be necessary to achieve high-patient enrollment performance, but this is not sufficient unless combined with either large patient volume or many participating sites.

Entities:  

Mesh:

Year:  2012        PMID: 23277765      PMCID: PMC3439228          DOI: 10.1200/JOP.2011.000507

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  16 in total

1.  Building community capacity to participate in cancer prevention research.

Authors:  Martha M McKinney; Bryan J Weiner; William R Carpenter
Journal:  Cancer Control       Date:  2006-10       Impact factor: 3.302

2.  The effects of managed care and competition on community-based clinical research.

Authors:  William R Carpenter; Bryan J Weiner; Arnold D Kaluzny; Marisa Elena Domino; Shoou-Yih Daniel Lee
Journal:  Med Care       Date:  2006-07       Impact factor: 2.983

Review 3.  Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Authors:  Lori M Minasian; William R Carpenter; Bryan J Weiner; Darrell E Anderson; Worta McCaskill-Stevens; Stefanie Nelson; Cynthia Whitman; Joseph Kelaghan; Ann M O'Mara; Arnold D Kaluzny
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

4.  The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer.

Authors:  Linda Laliberte; Mary L Fennell; George Papandonatos
Journal:  Med Care       Date:  2005-05       Impact factor: 2.983

5.  The community clinical oncology program: its effect on clinical practice.

Authors:  R B Warnecke; T P Johnson; A D Kaluzny; L G Ford
Journal:  Jt Comm J Qual Improv       Date:  1995-07

Review 6.  Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program.

Authors:  A D Kaluzny; R B Warnecke; L M Lacey; J P Morrissey; D Gillings; H Ozer
Journal:  J Natl Cancer Inst       Date:  1993-11-17       Impact factor: 13.506

7.  Adapting clinical trials networks to promote cancer prevention and control research.

Authors:  Bryan J Weiner; Martha M McKinney; William R Carpenter
Journal:  Cancer       Date:  2006-01-01       Impact factor: 6.860

8.  Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.

Authors:  Martha M McKinney; Bryan J Weiner; Virginia Wang
Journal:  Oncol Nurs Forum       Date:  2006-09-01       Impact factor: 2.172

9.  Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.

Authors:  C Klabunde; A Kaluzny; L Ford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Oct-Nov       Impact factor: 4.254

10.  Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.

Authors:  A D Kaluzny; L M Lacey; R Warnecke; J P Morrissey; E Sondik; L Ford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Apr-May       Impact factor: 4.254

View more
  13 in total

1.  Using Qualitative Comparative Analysis of Key Informant Interviews in Health Services Research: Enhancing a Study of Adjuvant Therapy Use in Breast Cancer Care.

Authors:  Ann Scheck McAlearney; Daniel Walker; Alexandra D Moss; Nina A Bickell
Journal:  Med Care       Date:  2016-04       Impact factor: 2.983

2.  Using qualitative comparative analysis to understand and quantify translation and implementation.

Authors:  Heather Kane; Megan A Lewis; Pamela A Williams; Leila C Kahwati
Journal:  Transl Behav Med       Date:  2014-06       Impact factor: 3.046

Review 3.  Cooperative Group Trials in the Community Setting.

Authors:  James Lloyd Wade; Nicholas J Petrelli; Worta McCaskill-Stevens
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

Review 4.  The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.

Authors:  Anne F Schott; John J Welch; Claire F Verschraegen; Razelle Kurzrock
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

5.  Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.

Authors:  Lauren M Hamel; Louis A Penner; Terrance L Albrecht; Elisabeth Heath; Clement K Gwede; Susan Eggly
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

6.  Organizational and physician factors associated with patient enrollment in cancer clinical trials.

Authors:  Sara R Jacobs; Bryan J Weiner; Bryce B Reeve; Morris Weinberger; Lori M Minasian; Marjorie J Good
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

7.  Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

Authors:  Michael E Roth; Ann M O'Mara; Nita L Seibel; David S Dickens; Anne-Marie Langevin; Brad H Pollock; David R Freyer
Journal:  J Oncol Pract       Date:  2016-03-29       Impact factor: 3.840

8.  Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.

Authors:  Bradford R Hirsch; Susan C Locke; Amy P Abernethy
Journal:  J Oncol Pract       Date:  2016-03-29       Impact factor: 3.840

9.  Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.

Authors:  Howard A Zaren; Suresh Nair; Ronald S Go; Rebecca A Enos; Keith S Lanier; Michael A Thompson; Jinxiu Zhao; Deborah L Fleming; John C Leighton; Thomas E Gribbin; Donna M Bryant; Angela Carrigan; Jennifer C Corpening; Kimberly A Csapo; Eileen P Dimond; Christie Ellison; Maria M Gonzalez; Jodi L Harr; Kathy Wilkinson; Andrea M Denicoff
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

10.  Qualitative Comparative Analysis: A Hybrid Method for Identifying Factors Associated with Program Effectiveness.

Authors:  Deborah Cragun; Tuya Pal; Susan T Vadaparampil; Julie Baldwin; Heather Hampel; Rita D DeBate
Journal:  J Mix Methods Res       Date:  2015-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.